UKPDS and beyond: Into the next millennium

Diabetes, Obesity and Metabolism

Volumn 1, Issue 1, 1999, Pages 13-22

  Krentz, Andrew J ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

BLOOD PRESSURE; DRUG EFFECT; ENDOCRINOLOGY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REVIEW; UNITED KINGDOM;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; ENDOCRINOLOGY; GREAT BRITAIN; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; PROSPECTIVE STUDIES; SULFONYLUREA COMPOUNDS;

EID: 0032601009     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.1999.00009.x     Document Type: Review

References (21)

1. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
2. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
3. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998; 317: 703-713.
4. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39). BMJ 1998; 7: 713-720.
5. Nathan DM. Some answers, more controversy, from UKPDS. Lancet 1998; 352: 832-833.
6. Orchard T. Diabetes: a time for excitement-and concern. BMJ 1998; 317: 691-692.
7. Mogensen CE. Combined high blood pressure and glucose in type 2 diabetes: double jeopardy. BMJ 1998; 317: 693-694.
8. UKPDS Group. UK Prospective Diabetes Study VIII: study design, progress and performance. Diabetologia 1991; 34: 877-890.
9. Ohkubo Y, Kishikawa H, Araki E. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin-dependent diabetes mellitus: a randomised prospective 6-year study. Diabetes Res Clin Prac 1995; 28: 103-117.
10. Leibowitz G, Cerasi E. Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetologia 1996; 39: 503-514.
11. Turner RC, Millns H, Neil HAW et al. Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS 23). BMJ 1998; 316: 823-828.
12. Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1970; 19 (Suppl): 789-930.
13. Baigent C, Peto R. Safety of metformin in type 2 diabetes mellitus. Diabetic Med 1999; 16: 89-90.
14. Sulkin TV, Bosman D, Krentz AJ. Contraindications to metformin therapy in patients with NIDDM. Diabetes Care 1997; 20: 925-928.
15. Riddle MC. Learning to use troglitazone. Diabetes Care 1998; 9: 1389-1390.
16. Colhoun HM, Dong W, Barakat MT, Mather HM, Poulter NR. The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94. Diabetic Med 1999; 16: 35-40.
17. Pahor M, Psaty BM, Furberg CT. Treatment of hypertensive patients with diabetes. Lancet 1998; 351: 689-690.
18. Evans AE, Krentz AJ. Benefits and risks of transfer from oral antidiabetic agents to insulin in patients with type 2 diabetes. Drug Safety 1999; in press.
19. Goyder E, Irwig L. Screening for diabetes: what are we really doing? BMJ 1998; 317: 1644-1666.
20. Watkins PJ. UKPDS: a message of hope and a need for change. Diabetic Med 1998; 15: 895-896.
21. American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 1999; 22 (Suppl): S27-S31.